Wednesday, October 1, 2025
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Biology

New Insights Suggest ALS May Be an Autoimmune Disease

October 1, 2025
in Biology
Reading Time: 3 mins read
0
65
SHARES
591
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

In a groundbreaking study, researchers from the La Jolla Institute for Immunology (LJI) and Columbia University Irving Medical Center have unveiled compelling evidence that the enigmatic neurodegenerative disorder amyotrophic lateral sclerosis (ALS) may, in fact, be driven by an autoimmune mechanism. ALS, which afflicts approximately 5,000 individuals annually in the United States, is characterized by a devastating progression leading to respiratory failure in the majority of patients within 14 to 18 months of diagnosis. Despite decades of research, the underlying cause of ALS has remained elusive until now.

The collaborative investigation centered on the role of CD4+ T cells—critical players in the immune system’s adaptive response—in patients afflicted with ALS. These immune cells were found to aberrantly target C9orf72, a protein highly expressed in neurons, effectively marking the nervous system as a target for immune-mediated attack. This self-reactivity underscores a fundamental characteristic of autoimmune diseases, where the body’s defense system erroneously recognizes its own proteins as foreign invaders.

Alessandro Sette, Ph.D., a co-lead on the study from the LJI, emphasized the novelty of these findings: “For the first time, we have unequivocal evidence demonstrating that ALS involves an autoimmune response targeting specific neuronal proteins.” Partnering with Columbia’s David Sulzer, Ph.D., the team used advanced immunological assays to detect heightened levels of inflammation-promoting CD4+ T cells in ALS patients, specifically those reactive against the C9orf72 protein. This discovery shifts the paradigm of ALS research by implicating immune dysregulation as a central contributor to disease pathology.

Surprisingly, the research delineated two distinct subpopulations among ALS patients based on their immune profiles. One subset exhibited highly inflammatory CD4+ T cell responses to C9orf72, correlating with shorter predicted survival times. Conversely, a second group demonstrated a more balanced immune signature, characterized by both inflammatory and regulatory, or anti-inflammatory, CD4+ T cells. These regulatory cells are paramount in mitigating excessive immune activation, thereby potentially slowing neuronal degradation and extending patient longevity.

This immunological dichotomy offers a plausible explanation for the perplexing heterogeneity in ALS progression. Notably, public figures such as Lou Gehrig succumbed rapidly to the disease, while others like Stephen Hawking defied odds by surviving for decades post-diagnosis. The newly identified protective role of regulatory CD4+ T cells suggests that modulating these immune components could become a strategic therapeutic avenue to prolong survival and enhance quality of life for ALS patients.

Further mechanistic insights reveal that under normal circumstances, the immune system balances aggressive responses to eliminate pathogens with counteracting signals that restrain immune activity, thus preserving healthy tissue integrity. ALS patients with longer survival times appear to maintain this delicate immunological equilibrium, where anti-inflammatory T cells temper the destructive potential of their inflammatory counterparts.

Looking forward, the research community anticipates harnessing these insights to develop targeted immunotherapies aimed at augmenting regulatory CD4+ T cell responses while damping harmful inflammation in ALS. Tanner Michaelis, the study’s first author and LJI research technician, highlighted the potential impact of these findings: “Identifying C9orf72 as a specific immune target opens new horizons for treatment strategies that are far more precise than current approaches.”

Moreover, the implications of this research transcend ALS, with co-leader Alessandro Sette proposing that similar autoimmune phenomena may underpin other neurodegenerative disorders, including Parkinson’s, Huntington’s, and Alzheimer’s diseases. This aligns with the emergent field of neuroimmunology, where accumulating evidence implicates immune components in the pathogenesis of multiple neurologic conditions previously thought to be purely degenerative.

The study builds on prior discoveries from the Sette Laboratory that connected autoimmunity and Parkinson’s disease, reinforcing the concept that immune dysregulation is a common denominator in neurodegeneration. Sette stated, “The involvement of immune cells in neurodegenerative diseases is becoming more of a rule than an exception, fundamentally altering our understanding of these pathologies and opening avenues for immune-based interventions.”

This landmark work was recently published in the prestigious journal Nature, signifying a major milestone in neuroimmune research. It was supported by multiple funding sources, including LJI & Kyowa Kirin, the Swedish Research Council, the Freedom Together Foundation, and the National Institute of Neurological Disorders and Stroke, underscoring the broad scientific interest and significance of these findings.

As the field advances, researchers remain cautious yet optimistic, recognizing that translating these discoveries into clinical therapies will necessitate rigorous testing and validation. Nonetheless, the identification of a direct autoimmune response against a neuronal protein in ALS patients marks a paradigm shift that promises to transform diagnostic and therapeutic approaches, offering renewed hope for patients facing this relentless disease.

Subject of Research: Cells
Article Title: Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis
News Publication Date: October 1, 2025
Web References: http://dx.doi.org/10.1038/s41586-025-09588-6
References: Alessandro Sette, David Sulzer et al., Nature, 2025
Image Credits: La Jolla Institute for Immunology
Keywords: Neuroscience; Immunogenetics; Immunology; Immune cells; Effector cells; Effector T cells; Immune disorders; Autoimmune disorders; Antigens; Neoantigens; Immune response; Adaptive immune response; T cell activation; Immunoreactivity; Neurons; Amyotrophic lateral sclerosis; Neurological disorders; Neurodegenerative diseases; Neuropathology; Diseases and disorders; Human health; Human biology

Tags: ALS patient prognosis and treatmentamyotrophic lateral sclerosis researchautoimmune disease characteristicsautoimmune mechanisms in ALSC9orf72 protein and ALSCD4+ T cells in neurodegenerationColumbia University ALS studyimmune system and neurological healthLa Jolla Institute for Immunology findingsneurodegenerative disorders and immunityneuroimmunology and ALS.novel insights into ALS
Share26Tweet16
Previous Post

Anna Nagurney Receives Prestigious 2025 INFORMS President’s Award

Next Post

New Study Uncovers Genetic and Developmental Distinctions Between Early and Later Autism Diagnoses

Related Posts

blank
Biology

Could Fungi Inspire the Future of Advanced Hydrogels?

October 1, 2025
blank
Biology

Unique β-Barrel Machinery Structure Found in Bacteroidota

October 1, 2025
blank
Biology

Jurassic Reptile Discovery Challenges Distinction Between Snakes and Lizards

October 1, 2025
blank
Biology

Light Quality Impacts Growth of Populus Schneideri

October 1, 2025
blank
Biology

Metabolic Response to Hypoxia in Altitude-Dwelling Rodents

October 1, 2025
blank
Biology

Targeting Gut Inflammation: The Crucial Role of ‘Unconventional’ Immune Cells

October 1, 2025
Next Post
blank

New Study Uncovers Genetic and Developmental Distinctions Between Early and Later Autism Diagnoses

  • Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27561 shares
    Share 11021 Tweet 6888
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    969 shares
    Share 388 Tweet 242
  • Bee body mass, pathogens and local climate influence heat tolerance

    646 shares
    Share 258 Tweet 162
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    513 shares
    Share 205 Tweet 128
  • Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function

    476 shares
    Share 190 Tweet 119
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Self-Efficacy and Test Anxiety Impact Math Performance More Than Co-Teaching, Study Finds
  • Could Fungi Inspire the Future of Advanced Hydrogels?
  • Breast Exam Uptake in Northern Ghana: Factors
  • Family Resilience: Key Link Between Functioning and Well-Being

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Blog
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 5,185 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading